Ronca-Testoni S, Galbani P, Ronca G
J Mol Cell Cardiol. 1985 Dec;17(12):1185-8. doi: 10.1016/s0022-2828(85)80114-0.
Creatine phosphate (CP) has been shown to possess some pharmacological properties. When added to cardioplegic solutions it improves their myocardial protection. Furthermore exogenous creatine phosphate shows an anti-arrhythmic effect in the experimental animal and appears to decrease lactate formation following haemorrhagic shock. These properties have been ascribed to the conservation of the tissue stores of ATP. Recently Down et al. have observed higher rat heart levels of ATP and creatine phosphate after the intravenous administration of creatine phosphate. Since it is difficult to find the conditions for an increase of the adenylate pool, it seems of interest to establish whether the ATP increase is due to a rise of the total adenylate pool or of the energy charge or of both. Similarly the higher creatine phosphate concentration may be ascribed to a variation of the CP/creatine ratio or to an increase in the creatine plus CP pool. In the present paper we report that the administration of creatine phosphate raises both the adenylate pool and the energy charge. An increase of creatine and the creatine phosphate pool was also observed.
磷酸肌酸(CP)已被证明具有一些药理特性。当添加到心脏停搏液中时,它可改善对心肌的保护作用。此外,外源性磷酸肌酸在实验动物中显示出抗心律失常作用,并且似乎能减少失血性休克后的乳酸生成。这些特性归因于ATP组织储备的保存。最近,唐恩等人观察到静脉注射磷酸肌酸后大鼠心脏中的ATP和磷酸肌酸水平更高。由于很难找到增加腺苷酸池的条件,确定ATP的增加是由于总腺苷酸池的增加、能荷的增加还是两者都增加似乎很有意义。同样,较高的磷酸肌酸浓度可能归因于CP/肌酸比值的变化或肌酸加CP池的增加。在本文中,我们报告磷酸肌酸的给药会增加腺苷酸池和能荷。还观察到肌酸和磷酸肌酸池增加。